JP2022543244A5 - - Google Patents
Info
- Publication number
- JP2022543244A5 JP2022543244A5 JP2022506659A JP2022506659A JP2022543244A5 JP 2022543244 A5 JP2022543244 A5 JP 2022543244A5 JP 2022506659 A JP2022506659 A JP 2022506659A JP 2022506659 A JP2022506659 A JP 2022506659A JP 2022543244 A5 JP2022543244 A5 JP 2022543244A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- approximately
- optionally substituted
- aminosterol
- symptom
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962882318P | 2019-08-02 | 2019-08-02 | |
| US62/882,318 | 2019-08-02 | ||
| US202063036828P | 2020-06-09 | 2020-06-09 | |
| US63/036,828 | 2020-06-09 | ||
| PCT/US2020/044392 WO2021025974A1 (en) | 2019-08-02 | 2020-07-31 | Human squalamine derivatives, related compositions comprising the same, and methods of using the same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022543244A JP2022543244A (ja) | 2022-10-11 |
| JP2022543244A5 true JP2022543244A5 (https=) | 2023-08-07 |
Family
ID=74503104
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022506659A Pending JP2022543244A (ja) | 2019-08-02 | 2020-07-31 | ヒトスクアラミン誘導体、それを含む関連組成物、およびそれを用いた方法 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20220372066A1 (https=) |
| EP (1) | EP4007765A4 (https=) |
| JP (1) | JP2022543244A (https=) |
| CA (1) | CA3149480A1 (https=) |
| WO (1) | WO2021025974A1 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12503485B2 (en) | 2019-08-02 | 2025-12-23 | Enterin, Inc. | Human aminosterol ENT-03 compounds, related compositions comprising the same, and methods of using the same |
| WO2021216399A1 (en) * | 2020-04-20 | 2021-10-28 | Enterin, Inc. | Pulmonary aminosterol compositions and methods of using the same to treat microbial infections |
| WO2022226116A1 (en) * | 2021-04-21 | 2022-10-27 | Oxeia Biopharmaceuticals, Inc. | Ghrelin treatment of brain dysfunction due to viral infection |
| WO2023038858A1 (en) * | 2021-09-10 | 2023-03-16 | Edifice Health, Inc. | Methods and compositions for diagnosing and treating covid-19 |
| CN113975278B (zh) * | 2021-10-29 | 2023-04-07 | 中国科学院昆明动物研究所 | 溴隐亭在制备治疗非洲猪瘟的产品中的应用 |
| WO2023146838A1 (en) * | 2022-01-25 | 2023-08-03 | Enterin, Inc. | Methods for treating or preventing neurodegenerative disease using a combination of aminosterols and an insulin compound |
| WO2023146842A1 (en) * | 2022-01-25 | 2023-08-03 | Enterin, Inc. | C25 r and s isomers of aminosterols and methods of making and using the same |
| CN118085053A (zh) * | 2022-11-25 | 2024-05-28 | 深圳先进技术研究院 | 以Inx5基因或以Inx5蛋白作为作用靶点的物质的应用 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1994020520A1 (en) * | 1993-03-10 | 1994-09-15 | Magainin Pharmaceuticals Inc. | Steroid derivatives, pharmaceutical compositions containing them, and their use as antibiotics or disinfectants |
| US5856535A (en) * | 1994-08-18 | 1999-01-05 | Magainin Pharmaceuticals, Inc. | Aminosterol ester compounds |
| US5792635A (en) * | 1995-06-07 | 1998-08-11 | Magainin Pharmaceuticals, Inc. | Method of inhibiting the sodium/proton exchanger NHE3 and method of inhibiting growth by administering squalamine |
| AU723663C (en) * | 1995-06-07 | 2001-11-01 | Magainin Pharmaceuticals, Inc. | Aminosterol compounds useful as inhibitors of the sodium/proton exchanger (NHE), pharmaceutical methods and compositions employing such inhibitors, and processes for evaluating the NHE-inhibitory efficacy of compounds |
| WO2009032321A2 (en) * | 2007-09-06 | 2009-03-12 | Genaera Corporation | A method for treating diabetes |
| MX367255B (es) * | 2012-04-20 | 2019-08-12 | Ohr Pharmaceutical Inc | Aminoesteroides para tratamiento de una enfermedad asociada con proteina fosfatasa 1b (ptp1b). |
| EP2934543B1 (en) * | 2012-12-20 | 2018-10-31 | Mount Desert Island Biological Laboratory | Stimulation and enhancement of regeneration of tissues |
| GB201303589D0 (en) * | 2013-02-27 | 2013-04-10 | Univ Swansea | Compound and method for the treatment of neurodegenerative conditions |
| GB201316050D0 (en) * | 2013-09-10 | 2013-10-23 | Univ Swansea | Deuterated compounds |
| EP3083656A1 (en) * | 2013-12-20 | 2016-10-26 | Prevacus Inc. | Synthesis of ent-progesterone and intermediates thereof |
| FR3055801B1 (fr) * | 2016-09-15 | 2020-10-30 | Virbac | Derives esters de squalamine pour le traitement des infections |
| FR3055802B1 (fr) * | 2016-09-15 | 2018-08-24 | Virbac | Derives amides de squalamine pour le traitement des infections |
| US20230125585A1 (en) * | 2019-08-02 | 2023-04-27 | Enterin, Inc. | Dosing protocols and regimens for aminosterol treatment |
| US12503485B2 (en) * | 2019-08-02 | 2025-12-23 | Enterin, Inc. | Human aminosterol ENT-03 compounds, related compositions comprising the same, and methods of using the same |
-
2020
- 2020-07-31 WO PCT/US2020/044392 patent/WO2021025974A1/en not_active Ceased
- 2020-07-31 US US17/631,887 patent/US20220372066A1/en not_active Abandoned
- 2020-07-31 CA CA3149480A patent/CA3149480A1/en active Pending
- 2020-07-31 JP JP2022506659A patent/JP2022543244A/ja active Pending
- 2020-07-31 EP EP20851006.5A patent/EP4007765A4/en not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022543244A5 (https=) | ||
| JP2022543242A5 (https=) | ||
| JP5932883B2 (ja) | 障害を処置するための方法および組成物 | |
| RU2302420C9 (ru) | Ингибиторы ксантин-фосфодиэстеразы v, способ их получения, фармацевтическая композиция, применение и способ лечения | |
| JPWO1998047505A1 (ja) | 神経ペプチドｙ受容体拮抗剤 | |
| CN1065531C (zh) | 用作一氧化氮合成酶抑制剂的氨基四唑衍生物 | |
| EP3157926B1 (en) | Organic compounds | |
| JP2013056911A (ja) | 運動障害の予防および／または治療剤 | |
| JP2010530901A5 (https=) | ||
| JP2013014629A (ja) | Ｒ（＋）プラミペキソールを用いた神経回復 | |
| CA2517893C (fr) | Application a titre de medicaments de derives de cholest-4-en-3-one, compositions pharmaceutiques les renfermant, nouveaux derives et leur procede de preparation | |
| JP2020023496A6 (ja) | 有機化合物 | |
| AU2015239112A1 (en) | 2,4-thiazolidinedione derivatives in the treatment of central nervous system disorders | |
| BE834794A (fr) | Acide 3-trihydroxygermano-propionique | |
| JP2002544232A (ja) | Ｎ−デスメチルゾピクロンの製造方法および使用方法 | |
| EP4180428A1 (en) | Crystalline imidazo[4,5-b]pyridine compound, pharmaceutical compositions, and their use in treating medical conditions | |
| EP4097119B1 (en) | Bile acid-gcpii inhibitor conjugates to treat inflammatory diseases | |
| JP6173352B2 (ja) | 筋萎縮性側索硬化症の治療方法 | |
| FR2894968A1 (fr) | Nouveaux derives de l'oxime de cholest-4-en-3-one, compositions pharmaceutiques les renfermant, et procede de preparation | |
| JP3509637B2 (ja) | 睡眠障害予防治療剤 | |
| WO2012097750A1 (zh) | 用于治疗阳痿的吡唑并嘧啶酮化合物和咪唑并三嗪酮化合物 | |
| JP5960695B2 (ja) | パンテニルドコサヘキサエノアート、ならびに心血管疾患を治療および予防するためのその使用 | |
| JPWO2006006617A1 (ja) | 中枢神経疾患発症後の機能障害の回復促進剤 | |
| JP2003523385A (ja) | 神経変性疾患の治療法 | |
| JP3494651B2 (ja) | 神経変性疾患の治療を目的とする医薬生成物の製造のためのエファロキサンおよびその誘導体の使用 |